Immunological studies in senile dementia of the Alzheimer type: evidence for enhanced suppressor cell activity

Annals of Neurology
A E MillerR Lipkowitz

Abstract

To examine immunological variables in senile dementia of the Alzheimer type (SDAT), we compared SDAT patients with elderly and young controls with regard to concanavalin A (Con A)-induced suppression, lymphocyte proliferation, interferon production, and serum immunoglobulin levels. The results showed exaggerated Con A suppression and reduced lymphocyte proliferation in SDAT patients compared to elderly control subjects. Interferon production after stimulation by Con A and immunoglobulin levels did not differ between SDAT and elderly control subjects. The results suggest impaired immunoregulatory mechanisms in patients with SDAT that may be related to the cause or course of SDAT. Alternatively, these immunological changes may be secondary to pathological changes in the central nervous system.

References

May 10, 1979·The New England Journal of Medicine·E L ReinherzS F Schlossman
Nov 8, 1979·The New England Journal of Medicine·E L ReinherzS F Schlossman
Jan 1, 1977·Cold Spring Harbor Symposia on Quantitative Biology·H Cantor, E A Boyse
Jan 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·P A Neighbour, B R Bloom
Jan 1, 1978·Clinical Immunology and Immunopathology·J P AntelB G Arnason
Jan 1, 1974·The Journal of Clinical Investigation·M E Weksler, T H Hütteroth
Jan 1, 1968·Scandinavian Journal of Clinical and Laboratory Investigation·C E Mogensen
Jul 1, 1968·The British Journal of Psychiatry : the Journal of Mental Science·G BlessedM Roth
Jul 8, 1967·Nature·A V PisciottaB Walsh
May 1, 1981·Neurology·P A NeighbourB R Bloom
Mar 1, 1980·The Journal of Experimental Medicine·A S KadishB R Bloom
Jul 17, 1980·The New England Journal of Medicine·E L ReinherzS F Schlossman
Jan 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·D Cohen, C Eisdorfer
Jan 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·C Eisdorfer, D Cohen
Sep 1, 1962·Archives of Neurology·A HIRANO, H M ZIMMERMAN

❮ Previous
Next ❯

Citations

Dec 1, 1990·Annals of Neurology·A B GravesM Raskind
Jan 1, 1990·Journal of Clinical Laboratory Analysis·S AntonaciE Jirillo
May 1, 1996·Molecular and Chemical Neuropathology·V K Singh
Aug 1, 1994·Molecular Neurobiology·V K Singh
Jan 1, 1989·Journal of Psychiatric Research·G D TollefsonM Garvey
Jul 1, 1992·Journal of Psychiatric Research·M W DyskenT Sunderland
Mar 15, 1992·Mechanisms of Ageing and Development·G E Gibson, L Toral-Barza
Jan 1, 1983·Neurobiology of Aging·J F FloodA Cherkin
Sep 1, 1986·Neurobiology of Aging·E HollanderK L Davis
Nov 21, 1986·Neuroscience Letters·R M Torack
Jan 1, 1989·Mutation Research·T A Smith, R F Itzhaki
Feb 1, 1985·Journal of Neuroimmunology·N KhansariH H Fudenberg
Apr 18, 1985·The New England Journal of Medicine·C PetersonJ P Blass
Apr 10, 1986·The New England Journal of Medicine·R Katzman
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J Bodycote, S Wolff
Oct 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·C PetersonJ E Goldman
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·C Peterson, J E Goldman
Sep 1, 1991·Acta Neurologica Scandinavica·S AragaK Takahashi
Mar 2, 1996·Lancet·I RaihaL Sourander
Jul 1, 1994·Neurobiology of Aging·A L Friedlich, L L Butcher
Oct 20, 1998·The International Journal of Neuroscience·M PopovićN Popović
Feb 1, 1997·The International Journal of Neuroscience·M PopovićL Rakić
Jan 1, 1985·Journal of the American Geriatrics Society·M S LeffellW A Steiger
Sep 1, 1987·Biological Psychiatry·G E GibsonJ P Blass
Mar 1, 1993·Journal of the American Geriatrics Society·R B Scott
Jun 1, 1983·The Australian and New Zealand Journal of Psychiatry·A S Henderson
Jun 1, 1985·Journal of the American Geriatrics Society·J P BlassM J Reding
Jul 1, 1988·Medicinal Research Reviews·W H MoosE R Gamzu
Sep 1, 1984·Drug Intelligence & Clinical Pharmacy·K L Rathmann, C S Conner
Jan 1, 1984·Neurochemical Pathology·J P Blass, A Zemcov
Jul 10, 2021·Frontiers in Cellular Neuroscience·Jenny LutshumbaAdam D Bachstetter
Apr 1, 1984·Annals of Neurology·A HeymanT Weinberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.